Staff Report | Thursday, February 19th, 2015
CNB heats up banking wars
Banking & Finance, Banking Industry, Latest news, Top StoriesCity National Bank has become the newest entrant in the competitive Santa Barbara banking market.
Staff Report | Tuesday, February 17th, 2015
Board says it ousted Sorensen from Select Staffing
Latest news, Top StoriesD. Stephen Sorensen, who steered the fortunes of Santa Barbara-based Select Staffing through explosive growth, bankruptcy and a merger that closed on Feb. 9, has been terminated for cause.
Staff Report | Monday, February 9th, 2015
REC Solar sells majority share to nation’s largest utility
Central Coast, Latest news, Technology, Top StoriesDuke Energy, headquartered in Charlotte, North Carolina, purchased the controlling stake in the solar company and announced it would invest $225 million in solar project financing as part of the deal.
Staff Report | Monday, February 9th, 2015
Milstien signs on as head of VCHC
Health Care & Life Science, Latest news, Top StoriesVentura County Health Center announced today that Kimberly Milstien will succeed Barry Fisher as its next CEO. She will assume the position March 1.
Staff Report | Friday, February 6th, 2015
Botanical Garden grows donations, announces new staff
Latest news, Nonprofits, Top StoriesThe Santa Barbara Botanical Gardens created its first endowed position and will renovate flora with the $15 million raised through its Seed the Future campaign.
Staff Report | Tuesday, February 3rd, 2015
Heritage Oaks Q4 profits jump 24%
Banking & Finance, Banking Industry, Central Coast, Latest news, Top StoriesThe increase was primarily due to the inclusion of Mission Community Bancorp’s operating results, which boosted pre-tax net income in the company’s fourth quarter financials.
Staff Report | Friday, January 30th, 2015
Amgen profit tops analysts’ estimates on drug sales, tax credit
East Ventura County, Health Care & Life Science, Latest news, Subscriber content, Technology, Top Stories, Tri-County Public CompaniesAmgen, the nation’s biggest biotech company, reported fourth-quarter profits that beat analysts’ estimates, aided by a tax benefit and higher-than-estimated sales of arthritis drug Enbrel.